VRTX Operating Cash Flow Growth

Vertex Pharmaceuticals · Operating Cash Flow Growth

VRTX logo

VRTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported11.61%
VRTX TTM Cash from Operations YoY % (-34.29% → 11.61%)
High-resolution chart · PNG

VRTX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vertex Pharmaceuticals Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
11.6083%
532.5819%
837.1904%
541.2533%
507.4576%
-124.8555%
-113.9259%
-119.2326%
-123.2044%
-3.1815%
-14.349%
8.2691%
1.244%
52.0769%
56.2285%
89.085%
89.4875%
-20.2514%
-18.7492%
-33.2902%
-19.5237%
63.0322%
107.3181%
123.1018%
77.5072%
53.4732%
23.5415%
21.5244%
52.7289%
61.3658%
50.34%
55.2465%
47.7756%
60.9316%
257.8701%
911.2851%
1,862.629%
398.136%
164.6093%
115.9913%
92.7106%
68.1634%
28.7933%
-30.0198%
-77.4099%
-237.112%
-895.1503%
-809.2309%
-461.5198%
-181.123%
-119.254%
-105.454%
-88.0495%
-40.2462%
86.3436%
238.9547%
191.1263%
153.2728%
122.6197%
7.9828%
-70.7191%
-42.6736%
-48.6115%
-35.3107%
18.7417%
-43.0605%
-88.7947%
-132.1991%
-347.3194%
-5.6178%
10.2956%
10.8403%
-203.4063%
-881.2443%
-1,023.3637%
-710.0949%
78.7283%
83.3785%
86.9372%
86.6497%
-3.9459%
-22.6119%
-21.0284%
-28.1716%
-15.7691%
14.3457%
15.1906%
3.3983%
-24.4973%
-70.5658%
-110.7432%
-540.1663%
-174.0063%
-232.9758%
-885.1251%
62.8924%
-26.1353%
-210.1258%
51.49%
-1,105.7062%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.